Literature DB >> 26264816

Treatment Considerations of Clinical Physician on Hypertension Management in Asia.

Satoshi Hoshide, Ji-Guang Wang, Sungha Park, Chen-Huan Chen, Hao-Min Cheng, Qi-Fang Huang, Chang-Gyu Park, Kazuomi Kario1.   

Abstract

BACKGROUND: There are important differences in the lifestyle and cardiovascular disease risks between Asian and Western populations. The objective of this survey was to investigate the awareness of these factors in the practice of hypertension management among Asian physicians.
METHODS: General practitioners and specialists in Asia were surveyed by questionnaire with regard to their management of hypertension. Physicians attending international conferences or meetings on hypertension between March and May 2014 were asked to participate.
RESULTS: In their treatment of hypertensive patients, 87% of the 133 respondents said they considered the Asian lifestyle and region-specific characteristics of hypertension in their treatment decisions, while just less than 11% did not. Almost all physicians (92%) recognized the necessity for an Asian-specific guideline for the management of hypertension. For patients with diabetes, 37% and 59% of the respondents used target systolic blood pressure (SBP) levels of 140 mmHg and 130 mmHg, respectively; for elderly patients, 37% and 53% of respondents used target SBP levels of 140 and l50 mmHg, respectively. Forty-eight percent of Asian physicians used calcium channel blockers as the first-line choice of antihypertensive drug while 34% selected angiotensin II receptor blockers, 14% angiotensin converting enzyme inhibitors and 3% diuretics.
CONCLUSION: Asian physicians consider that an Asian-specific guideline is needed for hypertension management in the Asian population.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26264816     DOI: 10.2174/1573402111666150812143155

Source DB:  PubMed          Journal:  Curr Hypertens Rev        ISSN: 1573-4021


  5 in total

Review 1.  Systemic Hemodynamic Atherothrombotic Syndrome and Resonance Hypothesis of Blood Pressure Variability: Triggering Cardiovascular Events.

Authors:  Kazuomi Kario
Journal:  Korean Circ J       Date:  2016-07-21       Impact factor: 3.243

Review 2.  Guidance on ambulatory blood pressure monitoring: A statement from the HOPE Asia Network.

Authors:  Kazuomi Kario; Satoshi Hoshide; Yook-Chin Chia; Peera Buranakitjaroen; Saulat Siddique; Jinho Shin; Yuda Turana; Sungha Park; Kelvin Tsoi; Chen-Huan Chen; Hao-Min Cheng; Takeshi Fujiwara; Yan Li; Van Minh Huynh; Michiaki Nagai; Jennifer Nailes; Jorge Sison; Arieska Ann Soenarta; Guru Prasad Sogunuru; Apichard Sukonthasarn; Jam Chin Tay; Boon Wee Teo; Narsingh Verma; Tzung-Dau Wang; Yuqing Zhang; Ji-Guang Wang
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-12-14       Impact factor: 3.738

Review 3.  Highlights of the 2019 Japanese Society of Hypertension Guidelines and perspectives on the management of Asian hypertensive patients.

Authors:  Satoshi Hoshide; Kazuomi Kario; Naoko Tomitani; Tomoyuki Kabutoya; Yook-Chin Chia; Sungha Park; Jinho Shin; Yuda Turana; Jam Chin Tay; Peera Buranakitjaroen; Chen-Huan Chen; Jennifer Nailes; Huynh Van Minh; Saulat Siddique; Jorge Sison; Arieska Ann Soenarta; Guru Prasad Sogunuru; Apichard Sukonthasarn; Boon Wee Teo; Narsingh Verma; Yuqing Zhang; Tzung-Dau Wang; Ji-Guang Wang
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-12-31       Impact factor: 3.738

4.  The identification of established modifiable mid-life risk factors for cardiovascular disease which contribute to cognitive decline: Korean Longitudinal Study of Aging (KLoSA).

Authors:  Yebeen Ysabelle Boo; Otto-Emil Jutila; Meghan A Cupp; Logan Manikam; Sung-Il Cho
Journal:  Aging Clin Exp Res       Date:  2021-02-04       Impact factor: 3.636

Review 5.  The HOPE Asia Network activity for "zero" cardiovascular events in Asia: Overview 2020.

Authors:  Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-02-24       Impact factor: 3.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.